Local delivery of IL-2 to atherosclerotic lesions in ApoE−/− mice or administration of IL-2/anti-IL-2 mAb immunocomplexes result in a decrease in atherosclerosis because Treg expansion. Here, IL2 is linked to atherosclerosis.